Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongli Liu

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
BMC Cancer|October 14, 2015
Establishment of monoclonal HCC cell lines with organ site-specific tropismsJinliang Wan, Duo Wen, Lili Dong, et al.
Frontiers in Microbiology|January 26, 2024
Molecular detection of Rickettsiales and a potential novel <i>Ehrlichia</i> species closely related to <i>Ehrlichia chaffeensis</i> in ticks (Acari: Ixodidae) from Shaanxi Province, China, in 2022 to 2023Xue Zhang, Wen Lv, Zhongqiu Teng, et al.
Scientific Reports|October 27, 2015
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEXLili Dong, Qiwen Tan, Wei Ye, et al.
Gynecologic Oncology|August 29, 2021
Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancerBonnita Werner, Nicole Yuwono, Jennifer Duggan, et al.
Molecular Therapy. Oncology|January 13, 2025
Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancerBayley Matthews, Michelle Wong-Brown, Dongli Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell CarcinomasNingning Cheng, Yong Liu, Guoqi Zhao, et al.
Cell Death & Disease|June 16, 2025
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axisGaoyan Tang, Xuelei Cao, Jiaqi Chen, et al.
Annals of Surgical Oncology|October 12, 2012
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluationChristina Fotopoulou, Rongyu Zang, Murat Gultekin, et al.
Optics Letters|October 1, 2025
Femtosecond laser-induced C<sub>Si</sub>V<sub>C</sub> color centers on the surface of N-doped 4H-SiCXiaoyu Sun, Xuhu Han, Haochen Wang, et al.
Therapeutic Advances in Medical Oncology|January 5, 2026
Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancerDongli Liu, Michelle Wong-Brown, Farhana Amy Sarker, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
BMC Cancer|October 14, 2015
Establishment of monoclonal HCC cell lines with organ site-specific tropismsJinliang Wan, Duo Wen, Lili Dong, et al.
Frontiers in Microbiology|January 26, 2024
Molecular detection of Rickettsiales and a potential novel <i>Ehrlichia</i> species closely related to <i>Ehrlichia chaffeensis</i> in ticks (Acari: Ixodidae) from Shaanxi Province, China, in 2022 to 2023Xue Zhang, Wen Lv, Zhongqiu Teng, et al.
Scientific Reports|October 27, 2015
Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEXLili Dong, Qiwen Tan, Wei Ye, et al.
Gynecologic Oncology|August 29, 2021
Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancerBonnita Werner, Nicole Yuwono, Jennifer Duggan, et al.
Molecular Therapy. Oncology|January 13, 2025
Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancerBayley Matthews, Michelle Wong-Brown, Dongli Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell CarcinomasNingning Cheng, Yong Liu, Guoqi Zhao, et al.
Cell Death & Disease|June 16, 2025
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axisGaoyan Tang, Xuelei Cao, Jiaqi Chen, et al.
Annals of Surgical Oncology|October 12, 2012
Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluationChristina Fotopoulou, Rongyu Zang, Murat Gultekin, et al.
Optics Letters|October 1, 2025
Femtosecond laser-induced C<sub>Si</sub>V<sub>C</sub> color centers on the surface of N-doped 4H-SiCXiaoyu Sun, Xuhu Han, Haochen Wang, et al.
Therapeutic Advances in Medical Oncology|January 5, 2026
Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancerDongli Liu, Michelle Wong-Brown, Farhana Amy Sarker, et al.
Pageof 8